AVE 0.00% 0.2¢ avecho biotechnology limited

prophase financials, page-19

  1. 118 Posts.
    You may be right kc about AOD, but the market would, I would think, like to see some figures rather than just talk of a 'successful launch' before bidding up the share price too much. The current share price bears this out.

    How long will that take? Elixia was launched in March 2010 - 12 months ago. Can you point me to any actual sales figures for Elixia?

    Regards.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.